Zephyrus Biosciences

Berkeley, United States Founded: 2013 • Age: 13 yrs Acquired By Bio-Techne
Single-cell protein analysis tools are commercialized for research markets.

About Zephyrus Biosciences

Zephyrus Biosciences is a Healthcare company based in Berkeley (United States) founded in 2013, and was acquired by Bio-Techne in March 2016. Single-cell protein analysis tools are commercialized for research markets. Zephyrus Biosciences has raised $1.5 million across 2 funding rounds from investors including NIH, Bio-Techne and Life Science Angels. The company was acqui-hired. Zephyrus Biosciences offers products and services including Antibodies, ELISA Kits, Simple Plex Assays, and Simple Western Instruments. Its focus areas include Life Sciences, Life Sciences Platforms and Tools and Diversified. Its competitors include Bio Rad, Quanterix and Biocare Medical; 2 of its 3 listed competitors have raised funding.

Company details

Zephyrus Biosciences was founded in 2013 in Berkeley, United States, within the biotechnology sector. The scWestern System is being commercialized to enable single-cell protein analysis for stem cell and cancer research. This system includes a hardware lab device, consumable chips used per experiment, and accompanying data analysis software. Operations focus on providing these components to research institutions.

Key Metrics
  • Total Equity Funding
    $1.5M (USD)

    in 2 rounds

  • Latest Funding Round
    $1.5M (USD), Seed

    Sep 2014

  • Investors
    NIH

    & 5 more

  • Acquired by
    Bio-Techne

    (Mar 2016)

Products & Services of Zephyrus Biosciences

Zephyrus Biosciences offers a comprehensive portfolio of products and services, including Antibodies, ELISA Kits, Simple Plex Assays, and Simple Western Instruments.

Antibodies
Research Reagents

Tools for detecting specific proteins in biological samples.

ELISA Kits
Assay Kits

Kits for measuring proteins and molecules in research applications.

Simple Plex Assays
Immunoassays

Automated assays for fast and reproducible protein measurement.

Simple Western Instruments
Analytical Instruments

Devices for complete protein analysis in scientific studies.

Apps and channels of Zephyrus Biosciences

its YouTube channel Bio-Techne has 509 subscribers and 30 videos.

Bio-Techne
YouTube 509 subscribers 30 videos Science & Technology
Open channel

Videos from Zephyrus Biosciences

The most watched videos on Zephyrus Biosciences's YouTube channel, Bio-Techne (509 subscribers). Click a video to play it here.

Introducing the Pala Cell Sorter and Single Cell Dispenser
253.5K views
Move Beyond Traditional Western Blots with Leo
50.9K views
Meet Jess: an Automated Western Blot System
14.6K views
How to set up a Maurice capillary isoelectric focusing (cIEF) assay
4.9K views

More on Bio-Techne.

Funding Insights of Zephyrus Biosciences

Zephyrus Biosciences has successfully raised a total of $1.5M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $1.5 million completed in September 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $1.5M
  • Total Rounds 2
  • Last Round Seed — $1.5M
  • First Round $350,000

    (Sep 2014)

  • Investors Count 5

All 2 funding rounds of Zephyrus Biosciences with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Sep 2014$350,000Grant––
Sep 2014$1.5MSeed–Life Science Angels
Valuation history

6 investors in total: 6 institutional.

Investors in Zephyrus Biosciences

Zephyrus Biosciences has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include NIH, Bio-Techne and Life Science Angels.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Life sciences startups are funded by a non-profit angel network.
lifescienceangels.comSunnyvale, United States
Tech & Life Sciences focused VC firm investing in early stage startups in the US
angelsforum.comMountain View, United States
Startups are accelerated by Stanford-backed program in Palo Alto.
startx.comPalo Alto, United States
Investments in life science startups are made by Mission BioCapital.
missionbiocapital.comSan Francisco, United States
Drug discovery services are provided to the biopharma sector.
1887nih.govUnited States
Developer of biotech reagents, instruments and clinical diagnostic products
1981bio-techne.comMinneapolis, United States
Premium access

Investor details for Zephyrus Biosciences

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Zephyrus Biosciences

3 dated milestones of Zephyrus Biosciences across 3 years, from founding to its latest funding, stage changes and deals.

  1. Founded Zephyrus Biosciences is founded.
  2. Funding First funding round of $350K.
  3. Exit Acquired by Bio-Techne.

Competitors of Zephyrus Biosciences

Zephyrus Biosciences has 3 listed competitors in our database, 2 of them funded. They include Bio Rad, Quanterix and Biocare Medical.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
bio-rad.com1952Hercules, United States10
Portfolio of products and services for life science research and clinical diagnostic markets
quanterix.com2007Cambridge, United States$99.5M141
Assay kits for ultra-sensitive biomarker detection are developed.
biocare.net1997Concord, United States$85M161
Primary antibodies and instruments for immunohistochemistry are manufactured.
Premium access

Detailed competitors of Zephyrus Biosciences

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Life Sciences Platforms & Tools

3 companies that operate in the same segment as Zephyrus Biosciences (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
1999New York, New York, United StatesUSD 41.5 M
AI-based solutions for health management are provided.
2015Dallas, Texas, United StatesUSD 2.8 B1,111
Real-world health data is provided for research and decisions.
2012Menlo Park, California, United StatesUSD 259.16 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • âś“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • âś“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • âś“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Zephyrus Biosciences

Premium access

Complete news archive for Zephyrus Biosciences

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Zephyrus Biosciences

Zephyrus Biosciences was founded in 2013 and raised its 1st funding round 1 year after it was founded.

Zephyrus Biosciences is headquartered in Berkeley, United States. It is registered at Berkeley, California, United States.

Zephyrus Biosciences is a funded company, having raised a total of $1.5M across 2 funding rounds to date. The company's 1st funding round was a Grant of $350K, raised on Sep 2014.

Zephyrus Biosciences was founded in 2013 in Berkeley, United States, within the biotechnology sector. The scWestern System is being commercialized to enable single-cell protein analysis for stem cell and cancer research. This system includes a hardware lab device, consumable chips used per experiment, and accompanying data analysis software. Operations focus on providing these components to research institutions.

Zephyrus Biosciences's top competitors include Biocare Medical, Quanterix and Bio Rad.

Zephyrus Biosciences offers Antibodies, ELISA Kits, Simple Plex Assays, and Simple Western Instruments.

Zephyrus Biosciences has 6 investors. Key investors include NIH, Bio-Techne, Life Science Angels, The Angels’ Forum, and StartX.

Yes. Zephyrus Biosciences was acquired by Bio-Techne in March 2016.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available